Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Dipyridamole analogue more potent than parent drug

April 19, 1996

Cancer Research Center, Moscow, presents MDR inhibitors at NCI-EORTC

April 19, 1996

ONYX-015 enters clinical testing

April 19, 1996

Japanese scientists present antitumor agents

April 19, 1996

Peptech neuropeptide antagonists in clinical studies

April 19, 1996

Taisho claims antitumor steroids

April 19, 1996

Agouron continues to discover MMP inhibitors

April 19, 1996

PD-154309 revealed at 211th ACS

April 19, 1996

AntiCancer, Celltech present gelatinase A inhibitor at NCI-EORTC

April 19, 1996

Estrasine presented at NCI-EORTC

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...